Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ATNF
- Price
- 0.85
- Stock movement up
- +0.16 (22.94%)
- Company name
- 180 Life Sciences Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.68M
- Ent value
- 8.22M
- Price/Sales
- 5.06
- Price/Book
- 0.45
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -65.47%
- 3 year return
- -90.08%
- 5 year return
- -81.54%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ATNF does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 5.06 |
| Price to Book | 0.45 |
| EV to Sales | 24.76 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.98M |
| EPS (TTM) | -3.18 |
| FCF per share (TTM) | -2.74 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 332.06K |
| Gross profit (TTM) | 95.81K |
| Operating income (TTM) | -6.37M |
| Net income (TTM) | -3.12M |
| EPS (TTM) | -3.18 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 28.85% |
| Operating margin (TTM) | -1918.57% |
| Profit margin (TTM) | -940.13% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 194.92K |
| Net receivables | 0.00 |
| Total current assets | 1.23M |
| Goodwill | 0.00 |
| Intangible assets | 9.24M |
| Property, plant and equipment | 0.00 |
| Total assets | 10.47M |
| Accounts payable | 2.09M |
| Short/Current long term debt | 473.14K |
| Total current liabilities | 6.38M |
| Total liabilities | 6.74M |
| Shareholder's equity | 3.73M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -2.69M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -2.69M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -83.61% |
| Return on Assets | -29.82% |
| Return on Invested Capital | -74.21% |
| Cash Return on Invested Capital | -63.94% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.72 |
| Daily high | 0.85 |
| Daily low | 0.72 |
| Daily Volume | 61K |
| All-time high | 4552.40 |
| 1y analyst estimate | 80.00 |
| Beta | 0.25 |
| EPS (TTM) | -3.18 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 13 May 2025 |
Downside potential
Loading...
Downside potential data
| ATNF | S&P500 | |
| Current price drop from All-time high | -99.98% | -12.89% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -68.20% | -11.07% |
| Avg time to new high | 25 days | 12 days |
| Max time to new high | 1007 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.68M
Marketcap category
Small-cap
Description
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren's Contracture; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, that focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Palo Alto, California.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page